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Background: Polymicrobial infections are responsible for significant mortality and morbidity in adults and children.
Staphylococcus epidermidis and Candida albicans are the most frequent combination of organisms isolated from
polymicrobial infections. Vascular indwelling catheters are sites for mixed species biofilm formation and pose a
significant risk for polymicrobial infections. We hypothesized that enhancement of biofilms in a mixed species
environment increases patient mortality and morbidity.
Results: Mixed species biofilms of S. epidermidis and C. albicans were evaluated in vitro and in a subcutaneous
catheter infection model in vivo. Mixed species biofilms were enhanced compared to single species biofilms of
either S. epidermidis or C. albicans. A mixed species environment increased catheter infection and increased
dissemination of S. epidermidis in mice. Microarrays were used to explore differential gene expression of S.
epidermidis in the mixed species biofilms. In mixed species biofilms, compared to single species S. epidermidis
biofilms, 2.7% of S. epidermidis genes were upregulated and 6% were down regulated. Staphylococcal autolysis
repressors lrgA and lrgB were down regulated 36-fold and 27-fold respectively. The role of biofilm extracellular DNA
was investigated by quantitation and by evaluating the effects of DNAse in a concentration and time dependent
manner. S. epidermidis specific eDNA was increased in mixed species biofilms and further confirmed by degradation
with DNAse.
Conclusions: Mixed-species biofilms are enhanced and associated with increased S. epidermidis-specific eDNA
in vitro and greater systemic dissemination of S. epidermidis in vivo. Down regulation of the lrg operon, a repressor
of autolysis, associated with increased eDNA suggests a possible role for bacterial autolysis in mixed species
biofilms. Enhancement and systemic dissemination of S. epidermidis may explain adverse outcomes after clinical
polymicrobial infections of S. epidermidis and C. albicans.
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Polymicrobial bloodstream infections are commonly
due to coagulase-negative Staphylococci (CoNS, most
commonly S. epidermidis) and Candida species [1-3].
Candida infections are important nosocomial infections
in intensive care units and approximately 25% of
patients with candidemia also have an associated bac-
teremia [4-6]. Polymicrobial infections are associated* Correspondence: mohanv@bcm.edu
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reproduction in any medium, provided the orwith significantly worse clinical outcomes than mono-
microbial infections [2,7,8]. Mortality due to poly-
microbial infections is twice that of monomicrobial
infections in non HIV infected adult patients, children
and neonates [9-11]. Pediatric polymicrobial infections
also increase length of intensive care, therapy, hospital
stay and healthcare costs [2].
Although high mortality has been observed in animal
models of polymicrobial infections of Staphylococci and
Candida, the mechanisms for increased mortality and
morbidity have not been fully elucidated [12-15].
In vitro interactions of Candida albicans and S. epi-
dermidis in mixed species biofilms and decreasedLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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teractions of S. epidermidis with Candida in mixed spe-
cies infections may influence gene expression that may
lead to enhanced virulence, biofilm formation, biofilm
dispersal and tissue pathology have not been well
studied.
A significant risk factor for human polymicrobial in-
fections is the presence of indwelling vascular catheters
that are sites for mixed species biofilm formation [2].
Biofilms are structured three dimensional microbial
communities that are attached to a surface and encased
in an extracellular matrix (ECM), which comprises
extracellular DNA (eDNA), polysaccharides and pro-
teins [18]. eDNA is formed by release of bacterial ge-
nomic DNA mostly by cell lysis or less commonly by
active excretion into the biofilm matrix in some bacteria
(e.g. Gammaproteobacteria) [18]. Extracellular DNA of
the biofilms facilitates the initial stage of adhesion to bio-
materials, forms the structural backbone and acts as glue
that promotes biofilm aggregation [19-21]. Clinically
significant mixed species biofilms of the pathogens
S. epidermidis and Candida and the specific role of eDNA
in mixed species biofilms have not been investigated.
In this study, we investigated mixed species biofilms of
S. epidermidis and C. albicans, both in vitro, and in a
clinically relevant mouse model of catheter biofilm infec-
tion, in vivo. We evaluated genome-wide S. epidermidis
transcriptional responses in mixed species biofilms with
C. albicans, to evaluate alteration in gene expression
that causes increased virulence and pathogenicity of
mixed species infections. We identified the significant
role of eDNA in the enhancement of mixed species bio-
films that may explain adverse outcomes due to clinical
polymicrobial infections.Results
Mixed species biofilms are larger than single species
biofilms of S. epidermidis and C. albicans
Representative confocal images of S. epidermidis,
C. albicans and mixed species biofilms grown in
microwell petridishes for 24 hr, stained with LIVE/
DEAD, at 40× magnification, in the green, red and
merged channels are presented in Figures 1A, 1B and
1C respectively. Mixed species biofilms that were de-
veloped using equal, half volumes of both organism
suspensions (only half CFU/ml of each) grew more
profusely than single species biofilms. Z-stacks of the
biofilms at 1 μm intervals in the z axis at 40× magnifi-
cation were analyzed by PHLIP software using
MATLAB imaging toolbox. Biovolume of S. epider-
midis (SE), C. albicans (CA) and mixed species bio-
films (n = 6 each) are represented in Figure 1D.
Biovolume of mixed species biofilms was significantlyincreased when compared to single species biofilms of
either S. epidermidis or C. albicans.
Scanning electron microscopy of explanted catheter
segments confirms catheter biofilm infection in vivo
Scanning electron microscopy (SEM) of explanted ca-
theter segments from mice on day 8 of insertion con-
firms catheter biofilm formation in the subcutaneous
catheter model of biofilm infection. When examined
using 250× magnification, S. epidermidis (Figure 2A, 2B)
and mixed-species biofilms (Figure 2C, 2D) are seen
coating the luminal surface of the catheter. S. epidermi-
dis biofilms (Figure 2B) when examined at 5000× mag-
nification, reveal grape-like clusters of Staphylococci.
Mixed species biofilms have more organisms and ex-
tracellular material compared to single species S. epi-
dermidis biofilms (Figure 2D). Candida hypha and
S. epidermidis in mixed species biofilms are presented
and labeled in Figure 2E and Figure 2F.
Evidence for increased catheter infection and
dissemination of S. epidermidis in mixed-species biofilm
infection in a subcutaneous catheter model
Figure 3A depicts catheter CFU/ml and Figure 3B blood
CFU/ml (systemic dissemination) of S. epidermidis and C.
albicans in single species and mixed species biofilm infec-
tions. Increased catheter biofilm formation was evidenced
by significantly higher mean number of viable S. epidermi-
dis in mixed species infection (2.04 × 109 CFU/ml) com-
pared to single species S. epidermidis biofilm infection
(1.22 × 108 CFU/ml) (p < 0.05). This is all the more signifi-
cant since the pre-insertion catheter CFU/ml in the mixed
species infection before subcutaneous insertion in mice
were 1.5 to 2 × 104 CFU/ml of S. epidermidis compared to
catheters incubated in single species S. epidermidis infec-
tion (3.5 to 4.5 × 105 CFU/ml). Since the pre-insertion
CFU/ml were lower in the mixed species infection com-
pared to single species S. epidermidis infection, adhesion
phase of the biofilm formation is not altered by the pre-
sence of C. albicans. However, presence of C. albicans in
the preincubation solution increases S. epidermidis biofilm
formation on catheters in vivo possibly by increased
biofilm aggregation resulting in increase in CFU/ml
(Figure 3A) and extracellular matrix. Mixed species envi-
ronment also increased dispersal of S. epidermidis as evi-
denced by increased blood dissemination of S. epidermidis
in mixed species infection (mean blood CFU/ml was
6.08 × 103 CFU/ml in mixed species infection compared
1.6 × 102 CFU/ml in single species S. epidermidis in-
fection, p < 0.05). C. albicans blood CFU/ml was similar
in single and mixed species infection even though
the catheter CFU/ml of Candida was significantly less
in mixed-species biofilms compared to single species
Candida biofilms (Figure 3A and 3B).
Figure 1 Mixed species biofilms are larger than single species biofilms. Twenty-four hour biofilms of S. epidermidis (SE) (A), C. albicans (CA) (B)
and mixed species biofilms (mixed) (C) were stained with LIVE/DEAD stain and examined by the Zeiss confocal microscope at 40× magnification.
Scale bars measure 100 μm. For each biofilm, three channels are presented; green channel showing viable organisms, red channel showing non-viable
organisms and the merged channel in that order respectively. Z-stacks of the biofilms at 1 μm intervals were analyzed by PHLIP software using
MATLAB image processing toolbox and biovolume (μm3) compared (D). Mixed species biofilms had significantly more biovolume than single species
biofilms (*#p <0.05).
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mixed species biofilms compared to single species S.
epidermidis biofilms
Microarray data have been deposited at the NCBI
gene expression and hybridization data repository(http://www.ncbi.nlm.nih.gov/geo/), [GEO accession num-
ber GSE35438]. S. epidermidis gene expression in mixed
species biofilms revealed 223 genes that changed ± 1.5
fold with an adjusted p value > 0.05. Upregulated S. epi-
dermidis genes (2.7%) included sarR and the hrcA
Figure 2 Electron micrographs confirm catheter biofilms in the mouse model of subcutaneous catheter infection. Subcutaneous catheter
segments explanted on day 8 of infection were examined by scanning electron microscopy. Electron micrographs of S. epidermidis biofilm
infection (A and B) and mixed-species biofilm infection (C, D and E) confirm biofilm formation on catheters in vivo. Mixed species biofilms where
predominance of S. epidermidis (Figure 2E) and C. albicans (Figure 2F) are labeled for S. epidermidis (SE) and C. albicans hyphae (CA).
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genes involved in nucleic acid metabolism and other
proteins (Additional file 1: Table S1). Down regulated S.
epidermidis genes (6%) included the highly down-
regulated lrgA and lrgB genes (repressors of autolysis,
36 fold and 27 fold change respectively), carbohydrate,
amino acid and nucleotide metabolism, transporters
and other proteins. Hierarchical clustering of data re-
sulted in separation of samples of S. epidermidis and
mixed-species biofilms, as expected (Figure 4A). The
cluster analysis illustrates the quality of the biological
replicates and the differential regulation between the
two sample types. We selected three genes of known
function that were upregulated > 3 fold (prfA, hrcA and
guaC) and the two most down regulated genes (lrgA
and lrgB) and performed real-time PCR to compare ourmicroarray results (Figure 4B). Real-time PCR results
were not statistically different from the microarray re-
sults for each of the genes evaluated (p > 0.05).
Evidence for increased eDNA in mixed-species biofilms
Quantification of the bacterial eDNA in the extracted
biofilm matrix using S. epidermidis specific primers
(lrgA, lrgB and bap) showed significantly increased bac-
terial eDNA in mixed-species biofilms of S. epidermidis
and C. albicans compared to single species biofilms of
S. epidermidis (Figure 5A). Extracted biofilm eDNA was
normalized for CFU/ml of the initial organism suspen-
sion used to form the biofilms. In order to understand
the contribution of eDNA from Candida, we assayed
the eDNA with Candida chromosomal gene specific
primers RIP, RPP2B and PMA1 (Figure 5B). Candida
Figure 3 Mixed species biofilms facilitate S. epidermidis infection and blood dissemination in the subcutaneous catheter biofilm model
in mice. Figure 3A depicts catheter CFU/ml and Figure 3B blood CFU/ml (systemic dissemination) of S. epidermidis and C. albicans in single
species and in mixed species infections. S. epidermidis CFU/ml in mixed species infection was significantly greater than single species S.
epidermidis infection both in catheters and in blood (p < 0.05). C. albicans CFU/ml from the catheter was significantly lower in mixed species
biofilms then single species candida biofilms but were similar in the blood after single and mixed-species infections. S. epidermidis (SE) biofilms
(single species) are shown in white bars, S. epidermidis in mixed species biofilms (Mixed (SE)) in gray bars, C. albicans (CA) (single species) in grainy
bars and C. albicans in mixed species biofilms (Mixed (CA) in (chequered bars).
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biofilms (< 30 ng/108 CFU/ml), none in S. epidermidis
single species biofilms and negligible in mixed species
biofilms. This confirms the predominance of bacterial
(Staphylococcal eDNA) in the extracellular matrix of
mixed-species biofilms.Figure 4 S. epidermidis transcriptome in mixed species biofilms and v
of the samples. Red color indicates upregulation and light blue down regu
of single species S. epidermidis and mixed species biofilms respectively. Two
(prfA, hrcA and guaC) were evaluated for microarray validation (Figure 4B).
gray bars. Real-time RT PCR shows consistent results with microarray (p > 0Disrupting eDNA by DNAse decreases single and
mixed-species biofilms
We further confirmed the presence of eDNA by estima-
ting the effects of DNA degradation on single and mixed
species biofilms. DNAse I treatment for 16 hrs disrupted
both single and mixed species biofilms of S. epidermidisalidation. Figure 4A represents a heat map with hierarchal clustering
lation. S1, S2, S3 and SC1, SC2 and SC3 represent 3 biological replicates
down regulated genes (lrgA and lrgB) and 3 upregulated genes
Results for microarray are shown in white bars and real-time RT PCR in
.05 for each gene tested).
Figure 5 Increased eDNA in the mixed-species biofilms confirmed by real-time RT PCR. Biofilm matrix was extracted and eDNA was
quantitated by real-time RT PCR using genomic DNA as standard. Primers for S. epidermidis genes (lrg A, lrgB and bap) were used to quantify the
eDNA (Figure 5A). Staphylococcal eDNA was increased significantly in the mixed species biofilms compared to single species S. epidermidis
biofilms (*, ** and ¶, p < 0.05). Candida gene specific primers (RIP, RPP2B and PMA1) were used to assess the contribution of eDNA by Candida in
mixed species biofilms (Figure 5B). Candida specific eDNA was present in Candida biofilms, absent in S. epidermidis biofilms and negligible
in mixed species biofilms. S. epidermidis biofilms are represented in white bars, mixed species biofilms in gray bars and Candida biofilms in
chequered bars.
Pammi et al. BMC Microbiology 2013, 13:257 Page 6 of 12
http://www.biomedcentral.com/1471-2180/13/257significantly and in a concentration dependent manner
compared to control biofilms (p < 0.05) (Figure 6A). In
order to understand the effects of DNAse at different
stages of biofilm formation, we exposed developing bio-
films to DNAse (0.65 mg/ml) at 0, 6 and 18 hrs and de-
veloped the biofilms up to 24 hrs (Figure 6B). At all
starting exposures, DNAse decreased biofilm formation
at 24 hrs significantly compared to controls (p < 0.05).
Percentage reduction in biofilms was more pronounced
for mixed species biofilms compared to single species
biofilms, indicating the higher eDNA content of the
mixed species biofilms (Figure 6C).
Discussion
We evaluated the morphology of mixed species biofilms
of S. epidermidis and C. albicans, in vitro. We observed
enhancement of biofilms in a mixed species environ-
ment. In a mouse subcutaneous catheter model of bio-
film infection, we noted increased catheter infection and
systemic dissemination of S. epidermidis in a mixed spe-
cies environment. To further explore the reasons for in-
creased pathogenicity of S. epidermidis in mixed species
biofilm infections with C. albicans, we evaluated the
transcriptome of S. epidermidis in a mixed species envi-
ronment and found that the repressors of autolysis, lrgA
and lrgB were highly down regulated. Down regulation
of repressors of autolysis, is associated with increased
eDNA in the biofilm matrix, possibly by increased bac-
terial autolysis. We confirmed the significance of in-
creased biofilm eDNA by evaluating its degradation by
DNAse.
Mixed species biofilms of S. epidermidis and C. albicans
were significantly thicker and voluminous compared to
single species biofilms of either organism in vitro. In-
creased thickness of mixed species biofilms can be due to
increase in the number of organisms or increase in the
extracellular matrix or possibly both. In mixed speciesbiofilm infections in vivo, at 8 days of infection, we ob-
served increase in catheter CFU/ml of S. epidermidis asso-
ciated with blood dissemination. Mixed species biofilms
in vivo may further be modified by environmental milieu
e.g. conditioning of the catheter implants with host pro-
teins that may increase biofilm adhesion and aggregation.
In mixed species biofilms of other bacteria with Candida
species, bacterial association with hyphae predominates
association with yeast cells [22,23]. Hogan et al. evaluated
interactions of Pseudomonas aeruginosa and Candida, and
found that Pseudomonas aeruginosa had a predilection for
the hyphal form without affecting the yeast form of the
fungus [22]. In studies of mixed species infections of
S. aureus and C. albicans, similar to P. aeruginosa, adhe-
rence to the Candida hyphae was nearly 30-fold more than
adherence to the yeast form of Candida [23]. In our expe-
riments (data not shown) we found adherence of S. epi-
dermidis to both yeasts and hyphae of Candida which may
facilitate mixed species biofilms of these two organisms
and partly contribute to the increased clinical frequency of
mixed species biofilm infections of C. albicans and S. epi-
dermidis. The yeast and hyphal forms of C. albicans may
act as a scaffold on which biofilms of S. epidermidis are
formed [23]. Candida infection is associated with tissue in-
vasion by hyphae and it been hypothesized that staphylo-
coccal tissue infection is facilitated by its association with
Candida hyphae [23]. Synergistic effects of C. albicans and
S. epidermidis have been reported by other investigators
[16,17]. In mixed species biofilms of C. albicans and
S. epidermidis, presence of slime producing strains of
S. epidermidis decreases antifungal susceptibility related
to decreased penetration of the fluconazole through the
ECM and conversely the fungal cells protected slime
negative S. epidermidis against vancomycin [16]. In an
in vitro study of mixed species biofilms of C. albicans
and S. epidermidis, enhanced the growth of S. epidermi-
dis was observed [17].
Figure 6 Biofilm disruption of eDNA by DNAse. Twenty four hr
single species and mixed species biofilms were exposed to DNAse
for 16 hr at concentrations from 0 (buffer) to 1.25 mg/ml
(Figure 6A). Biofilm formation was significantly decreased by DNAse
at 1.25 mg/ml compared to buffer (p < 0.05) and the biofilm
disruption effect was concentration dependent. A time course
experiment was performed by the addition of DNAse (0.65 mg/ml)
at 0, 6 or 18 hrs and biofilm development continued till 24 hr and
quantitated (Figure 6B). Both S. epidermidis and mixed species
biofilm formation were significantly decreased (p < 0.05) after
addition of DNAse at the three time-points of DNAse exposure.
Percentage reduction in biofilms was more pronounced in mixed
species biofilms compared to single species S. epidermidis biofilms
(Figure 6C). S. epidermidis biofilms are represented in white squares
and bars and mixed species biofilms in gray squares and bars.
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catheter biofilm infection to evaluate the clinical impli-
cations of mixed species biofilm infection [24]. In mixed
species biofilms, catheter biofilm infection of S. epider-
midis increased in the presence of C. albicans. Pre-
insertion cultures revealed lower catheter infection ofS. epidermidis in mixed species infection compared to
single species S. epidermidis but on day 8 of insertion
in vivo, we found increased catheter infection of S. epi-
dermidis in the mixed species infection. This suggests
that mixed species environment facilitates biofilm aggre-
gation and not the initial phase of S. epidermidis adhe-
sion to catheters. Enhanced biofilm aggregation was
associated with enhanced dispersal that led to increased
systemic dissemination of S. epidermidis in the mixed
species infection. Increased virulence and mortality has
been described in mouse models of dual infection with
C. albicans and S. aureus but not with S. epidermidis
[12-14]. Peters et al. using proteomic techniques found
that the global transcriptional repressor of virulence was
down regulated thereby increasing virulence of the dual
species biofilms of S. aureus and C. albicans [23]. En-
hancement of biofilms, increased catheter infection and
dissemination of S. epidermidis in mixed species biofilms
in vivo may partly explain clinical therapeutic failures
and contribute to increased mortality and morbidity in
polymicrobial infections.
We performed microarrays to delineate changes in
staphylococcal gene expression that lead to increased
catheter infection and dissemination in mixed species bio-
films with C. albicans. We noted that the lrg operon com-
prising lrgA and lrgB was highly down regulated (36 fold
and 27 fold change respectively) in mixed species biofilms.
Lrg operon along with the cidR operon represents the
molecular elements of programmed cell death or apop-
tosis in Staphylococcus aureus [25-27]. The lrg operon is a
repressor of murein hydrolase activity that hydrolyzes
components of the cell wall, involved in autolysis. Lrg pro-
tein has also been shown to affect antibiotic tolerance,
biofilm formation (by release of eDNA which is a struc-
tural component of the biofilm) and acetoin production in
S. aureus [25,26,28,29]. Lrg operon is regulated by the
LytSR two component regulatory system in S. aureus and
transcriptional regulators agr and sar that regulate viru-
lence also influence the lrg operon [28,29]. Down regula-
tion of the lrg operon (autolysis repressors) in mixed
species biofilms is associated with enhanced release of
eDNA possibly by autolysis [25,30]. Extracellular DNA
plays a significant role in biofilm aggregation [18,19] and
it is conceivable that increased eDNA enhances aggre-
gation of mixed species biofilms of S. epidermidis and
C. albicans. Most bacteria have cardiolipin synthases that
convert bacterial membrane phosphatidyl glycerol to car-
diolipin, during the transition from logarithmic phase to
the stationary phase and may help survival during pro-
longed high salt stress conditions [31]. S. aureus and
S. epidermidis have 2 ORFs cls1 and cls2 [32] and we
found cardiolipin synthetase (cls2) was significantly down
regulated. Other down regulated genes included those
associated with carbohydrate, amino acid and nucleotide
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whole may be metabolically less active compared to ac-
tively dividing planktonic organisms and that may explain
the down regulation of metabolic processes and overall
more down regulated genes (6%) than upregulated genes
(2.7%) [33].
Genes upregulated in mixed species biofilms include
transcriptional regulators (sarR and hrcA the heat indu-
cible transcriptional repressor), genes associated with
nucleic acid metabolism, some transporters and other pro-
teins. sarR is known inhibitor of sarA, a transcriptional
regulator that represses extracellular proteases and that
may influence virulence determinants in S. aureus [34-36]
but its role in S. epidermidis is not known. Therefore the
net effect of sarR upregulation is to facilitate secretion of
extracellular proteases that may function as virulence fac-
tors. Heat shock protein GrpE protein of the DnaK family
of shock proteins is upregulated indicating an adaptive re-
sponse to polymicrobial stress by S. epidermidis in mixed
species biofilms. Adaptation to competition for iron in
mixed species environments is facilitated by the increased
transcription of transferrin receptor, which facilitates
uptake of iron from human transferrin by a receptor-
mediated energy dependent process [37,38]. Genes related
to nucleic acid and glycerol metabolism (guaC, purC,
purM, glpD, apt and uraA) were also upregulated.
We measured the eDNA content in the extracellular
matrix of single and mixed-species biofilms and con-
firmed that S. epidermidis derived eDNA predominated
in mixed species biofilms. Candida derived eDNA was
barely detected indicating the predominant role for bac-
terial eDNA in the enhancement of mixed-species bio-
films. Low Candida eDNA may be also partly due to
decreased growth of Candida in mixed species biofilms.
Indirectly, this indicates that bacterial autolysis, the most
important mechanism for producing bacterial eDNA, is
strongly implicated in the enhancement of mixed species
biofilms.
We evaluated the effects of disrupting eDNA by
DNAse on mature (24 hr) and developing single and
mixed species biofilms of S. epidermidis and C. albicans.
DNAse decreased biofilm metabolic activity (as mea-
sured by XTT method) by a concentration dependent
manner in both single and mixed species biofilms. We
also evaluated the effects of DNAse on a developing bio-
films by initiating exposure to DNAse at different time
points (0, 6 and 18 hrs). Exposure at earlier time-points
would decrease adhesion of the microbial cells and
exposure later would affect biofilm aggregation. We ob-
served that DNAse decreased biofilm formation signifi-
cantly at both adhesion and aggregation stages in biofilm
development. The reduction in biofilm formation as a
percentage of that of untreated biofilms was more pro-
nounced in mixed species biofilms compared to singlespecies biofilms, due to an increased eDNA content in
the mixed species biofilms. Other investigators have
found similar inhibiting effects of DNAse on biofilm
adhesion and aggregation outlining the essential role of
eDNA in biofilm development [39-41].
We confirmed increased eDNA in mixed species bio-
films by quantitation of eDNA in the biofilm extracellular
matrix. Increased eDNA in the biofilm matrix is probably
caused by autolysis as active secretion of eDNA has not
been reported in S. epidermidis biofilms. Staphylococcal
biofilm aggregation is enhanced by eDNA and increased
quantity of eDNA may explain the increased thickness of
mixed-species biofilms. Significant down regulation of re-
pressors of autolysis (lrg operon) also point to increased
bacterial autolysis in mixed species biofilms. The lrg op-
eron that represses murein hydrolase activity and thereby
autolysis in S. aureus has not been studied in S. epidermi-
dis so far. In Staphylococcus aureus, cidA and lrgA genes
encode homologous hydrophobic proteins that function
similar to bacteriophage coded holin (causes autolysis) and
antiholin (inhibits autolysis), respectively. The S. aureus
cidB and lrgB genes also encode homologous hydrophobic
proteins, but their functions are unknown [42]. In a model
proposed by Bayles et al., the LytSR two-component regu-
latory system senses decreases in cell membrane potential
due to cell membrane damage and responds by inducing
lrgAB transcription. The CidR protein, a LysR-type tran-
scription regulator, enhances cidABC in response to car-
bohydrate metabolism that enhance murein hydrolase
activity thereby enhancing autolysis [26,43]. LrgAB operon
in S. aureus also influences penicillin (that causes cell lysis)
tolerance [25]. In S. epidermidis, LytSR knockout strain
exhibited decreased extracellular murein hydrolase activity
and mildly increased biofilm formation but did not differ
in Triton X-100 mediated autolysis or in murein hydrolase
zymogram patterns from the parent strain [44]. Mutation
of SaeRS (another two component signal system) in S. epi-
dermidis increased autolysis and biofilm forming ability
[45]. Association of autolysis and increased biofilm forma-
tion is also confirmed by studies on autolysin atlE in S.
epidermidis [46]. Therefore, autolysis and release of eDNA
has a significant role to play in Staphylococcal biofilm for-
mation and enhancement of mixed species biofilms.
The limitations of the study include using a single cli-
nical strain each of S. epidermidis and C. albicans. Fin-
dings of this study will have to be confirmed using
multiple strains of S. epidermidis and C. albicans. The
subcutaneous catheter biofilm infection in mice is an
appropriate and reproducible model to evaluate foreign
device biofilm infections i.e. pacemaker and shunt infec-
tions but an intravenous catheter model will be more
appropriate for indwelling vascular catheter infections.
Nevertheless the subcutaneous catheter model has been
successfully used to study biofilm infections and to
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riments, S. epidermidis probes on the microarray that
might hybridize with Candida RNA were eliminated in the
design of the microarray. Also, those probes that actually
hybridized with Candida RNA were also eliminated from
data analysis. It is possible that some transcriptome data
was lost due to the elimination of Candida cross-reacting
probes.
Conclusions
Biofilms are enhanced in a mixed-species environment
of S. epidermidis and C. albicans both in vitro and
in vivo. Enhanced mixed-species biofilms are associated
with increased S. epidermidis-specific eDNA in vitro and
greater systemic dissemination of S. epidermidis in vivo.
Down regulation of the lrg operon, a repressor of auto-
lysis was associated with increased eDNA. We propose
that bacterial autolysis may play a significant role in the
enhancement of mixed species biofilms and which needs
to be confirmed by mechanistic studies. Enhancement of
biofilms and systemic dissemination of S. epidermidis in
polymicrobial environments may explain increased cli-
nical mortality and morbidity. Elucidation of polymicro-
bial interactions in mixed species biofilms may lead to
novel strategies to treat human polymicrobial infections.
Methods
Organisms, strains and culture conditions
Human isolates of S. epidermidis (strain 1457) and
C. albicans (strain ATCC 32354) were used in this
study. S. epidermidis were incubated in tryptic soy broth
(TSB) broth for 2 hr from overnight TSB agar plates.
C. albicans was plated on Sabouraud’s dextrose agar
(SDA) overnight and grown in Yeast Peptone Dextrose
(YPD) broth for 4 hr. Both organisms were adjusted to an
optical density (O.D.) of 0.3 in RPMI 1640 (107 CFU/ml of
S. epidermidis and 105 CFU/ml of C. albicans).
In vitro biofilm model
Biofilms were formed on optical microwell Petri dishes
(MaTtek Corp, USA) that have a cover slip at the center
to facilitate confocal microscopy. Single species biofilms
were developed by incubating suspensions of S. epider-
midis or C. albicans (O.D. 0.3) and mixed species biofilms
by equal half volumes of both the organism suspensions,
for 24 hr. Supernatants were discarded, biofilms washed
with PBS, stained with LIVE/DEAD stain (Molecular
Probes, USA). Bacteria with intact cell membranes (live
cells) are stained green and those with damaged mem-
branes, red. Biofilms were examined by the Nikon A1 con-
focal microscope (Nikon Instruments Inc., NY, USA)
using fluorescein (green) and Texas red (red) band pass
filter sets. Confocal images were obtained in serial sections
at 1 μm intervals along the z-axis (40× magnification).The z-stack images were analyzed using software PHLIP
in the MATLAB image processing toolbox, for biofilm
biovolume (in μm3) [47].
Mouse model of subcutaneous catheter biofilm infection
The protocol for animal experiments was approved by The
Institutional Animal Care and Use Committee at Baylor
College of Medicine. A biofilm infection model in mice
with subcutaneously implanted catheters described pre-
viously was used [24]. Teflon catheters (Surflo, Terumo
Corporation, Japan) sized 18G, 1½″ were pre-incubated in
S. epidermidis, C. albicans or both organism suspensions
(O.D. 0.3) for 2 hr, in order to facilitate biofilm develop-
ment. Catheter segments were inserted subcutaneously in
3 week old weaned FVB albino mice. Catheter cultures
were performed prior to subcutaneous insertion in serial
dilution plating after 24 hr of incubation. Pre-insertion,
catheters in suspensions of S. epidermidis yielded 3.5 to
4.5 × 105 CFU/ml, those in C. albicans yielded 6 to 6.5 to
104 CFU/ml and catheters immersed in mixed species
suspensions yielded 1.5 to 2 × 104 and 6 to 6.5 to 103
of S. epidermidis and C. albicans respectively. Animals
were euthanized on day 8; catheter and blood cultures
were evaluated quantitatively for the two organisms
and catheter biofilms examined by scanning electron
microscopy.
Scanning electron microscopy
A 5 mm sample was cut from each explanted catheter seg-
ment from mice with subcutaneous catheter infection.
The catheter samples were cut in cross sections and fixed
with 2% glutaraldehyde, followed by fixation with osmium
tetroxide, tannic acid and uranyl acetate. Fixation was
followed by a series of ethanol dehydration steps and
samples were sputter-coated with gold palladium. The
samples were then scanned by electron microscopy for
biofilms at different degrees of magnification.
Microarrays
Cultures and RNA isolation for microarrays
Single species biofilms of S. epidermidis (strain 1457)
and C. albicans (strain 32354) and mixed species bio-
films were formed on 6-well tissue culture plates. Five
ml of organism suspensions (O.D. 0.3, S. epidermidis
107 CFU/ml or C. albicans 105 CFU/ml) or 2.5 ml each
for mixed-species biofilms for 24 hr. RNA was harvested
from single species and mixed-species biofilms using
RNeasy Mini kit (Qiagen) and Fast-RNA Pro-BLUE kit
(MP Biomedicals) according to manufacturer’s instruc-
tions. Total RNA from 3 biological replicates each for
S. epidermidis and mixed species biofilms was shipped
to Mycroarray (www.mycroarray.com, Ann Arbor, USA)
for hybridization to microarrays.
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In situ synthesized oligonucleotide microarrays were ma-
nufactured by Mycroarray and probe sequence designed
using a proprietary version of OligoArray 2.0 [48]. Arrays
were synthesized on slide-sized glass substrates and each
slide had an array composed of 40,962 spots, of which
33,715 spots contain 45mer probes for S. epidermidis
genes, 525 empty features without a probe and 720 fea-
tures with Mycroarray quality control probes. In addition,
there are 6000 probes for randomly selected Candida
genes to assess potential cross hybridization with S. epi-
dermidis genes. There were up to 3 probes per gene and 5
identical replicates of each S. epidermidis probe. Multiple
probes per gene format was chosen to account for the
genetic variability between S. epidermidis 1457 strain
used in our experiment compared to strain RP62A used
in the microarray probe design. Also, to avoid theo-
retical cross contamination, S. epidermidis probes were
blasted against C. albicans genome sequence (http://
www.candidagenome.org) and S. epidermidis probes
with potential match with C. albicans sequences were
removed from the array design. Separately, RNA from
pure C. albicans cultures were also hybridized to the
arrays and cross-hybridizing probes were removed from
data analysis.
Microarray hybridization and data analyses
Microarray experiments were performed by Mycroarray
and data analyzed at Texas Children’s Hospital. Briefly,
the purified mRNA was amplified and incorporated with
amino allyl-UTP for indirect labeling with fluorescent
dyes. Dynamic hybridization to the 40 K arrays was
performed using Agilent gasket slides and incubation at
45°C for 20 hr following which the slides were washed
and scanned using Axon 4000B scanner (Molecular
Devices) at 5 micron resolution. Signal intensity values
were extracted from scanned images using GenePix® Pro
6 software (Molecular Devices). The raw gpr files were
loaded in Genespring GX 11.5, the data log2 trans-
formed; background corrected, and normalized using the
Quantile algorithm. Hierarchical clustering map was
generating using Euclidean algorithm with the average
linkage rule. Differential gene expression between the
two samples groups (S. epidermidis and mixed species
biofilms) was evaluated by unsupervised unpaired t-test
on the log2 transformed mean data. A fold-change ratio
(mixed species biofilms vs. S. epidermidis biofilms) was
calculated with a fold change cutoff of 1.5 and p-value of
0.05. Probe set lists were trimmed to represent S. epider-
midis and analyzed using unpaired t-test and Benjamini-
Hochber multiple-testing correction to generate targeted
lists of differential expression. Microarray expression
patterns were validated using real-time PCR using three
upregulated and two down regulated genes.Quantitation of eDNA in single and mixed-species
biofilms
Biofilm matrix and eDNA were extracted from 24 hr
single species S. epidermidis biofilms and mixed species
biofilms of S. epidermidis and C. albicans as described
previously [30,39,46]. The extracellular matrix from har-
vested biofilms was carefully extracted without cell
lysis and contamination with genomic DNA as described
[30,39,46]. The amount of eDNA was quantified by real-
time RT-PCR using standard curves of known quantities
of S. epidermidis and C. albicans genomic DNA. Real-
time PCR was performed using the SYBR Green kit
(Qiagen) and primers for 3 chromosomal genes of S. epi-
dermidis, lrgA, lrgB and bap (whose primers for RT-PCR
were previously optimized in our lab) or stably expressed
chromosomal genes of C. albicans RIP, RPP2B and
PMA1 [49]. The amount of measured eDNA was nor-
malized for 108 CFU organisms in the initial inoculation.
Effects of DNAse on single and mixed species biofilms
Concentration dependent effects of DNAse I (Sigma or
Roche, USA) was studied by exposing 24 hr single and
mixed-species biofilms, at 0 to 1.25 mg/ml concentrations
DNAse I for 16 hr and residual biofilm evaluated by mea-
suring absorbance at 490 nm after XTT reduction [50]. A
time course experiment was performed by the addition of
DNAse (0.65 mg/ml) at 0, 6 or 18 hrs of biofilm develop-
ment. The biofilms were developed for a total of 24 hr
and metabolic activity quantitated by XTT method and
measuring absorbance at 490 nm. Percentage reduction in
biofilms compared to controls was evaluated for single
and mixed species biofilms at DNAse exposures starting
at 0, 6 or 18 hrs.
Data deposition
The microarray dataset supporting the results of this art-
icle has been deposited and available at the NCBI gene
expression and hybridization data repository (http://
www.ncbi.nlm.nih.gov/geo/), [GEO accession number
GSE35438].
Additional file
Additional file 1: Table S1. Differential expression of S. epidermidis
genes in mixed-species biofilms.
Abbreviations
CONS: Coagulase-negative staphylococci; eDNA: Extracellular DNA;
ECM: Extracellular matrix; O.D.: Optical density; CFU/ml: Colony forming
units/ml; RT-PCR: Reverse transcriptase polymerase chain reaction;
TSB: Tryptic soy broth; SDA: Sabouraud’s dextrose agar; YPD: Yeast peptone
dextrose.
Competing interests
None of authors have competing financial or non-financial interests associated
with this article.
Pammi et al. BMC Microbiology 2013, 13:257 Page 11 of 12
http://www.biomedcentral.com/1471-2180/13/257Authors’ contributions
MP conceived the project, did the biofilm experiments in vitro and in vivo
including imaging studies, analyzed data and wrote the manuscript. RL
assisted in the biofilm experiments, in vitro and in vivo experiments and
imaging studies. JH performed the electron microscopy studies of the
catheter biofilms. TM carried out the microarray analyses and participated in
the revision of the manuscript. JM contributed by critical intellectual input




Assistant Professor and Neonatologist, Baylor College of Medicine and Texas
Children’s Hospital, Houston, Texas.
Rong Liang MD
Research Associate, Baylor College of Medicine and Texas Children’s Hospital,
Houston, Texas.
John Hicks MD PhD
Professor of Pathology, Baylor College of Medicine and Texas Children’s
Hospital, Houston, Texas.
Toni-Ann Mistretta PhD
Senior Biostatistician, Baylor College of Medicine & Texas Children's
Microbiome Center
James Versalovic MD PhD
Professor and Chief of the Department of Pathology, Baylor College of
Medicine and Texas Children’s Hospital, Houston, Texas.
Acknowledgements
We acknowledge the insightful discussions of members of the Versalovic lab.
We also acknowledge Vital Pannaraj PhD and Alejandra Diaz PhD for their
advice on microarrays and real time quantitative PCR experiments. This
project was supported by the Integrated Microscopy Core at Baylor College
of Medicine with funding from the NIH (HD007495, DK56338, and
CA125123), the Dan L. Duncan Cancer Center, and the John S. Dunn Gulf
Coast Consortium for Chemical Genomics. We also thank Paul Fey PhD for
his helpful comments and critique.
Author details
1Section of Neonatology, Department of Pediatrics, Texas Children’s Hospital
& Baylor College of Medicine, 6621, Fannin, MC: WT 6-104, Houston, TX
77030, USA. 2Department of Pathology, Texas Children’s Hospital & Baylor
College of Medicine, Houston, TX 77030, USA.
Received: 25 July 2013 Accepted: 12 November 2013
Published: 14 November 2013
References
1. Karlowicz MG, Furigay PJ, Croitoru DP, Buescher ES: Central venous catheter
removal versus in situ treatment in neonates with coagulase-negative
staphylococcal bacteremia. Pediatr Infect Dis J 2002, 21(1):22–27.
2. Sutter D, Stagliano D, Braun L, Williams F, Arnold J, Ottolini M, Epstein J:
Polymicrobial bloodstream infection in pediatric patients: risk factors,
microbiology, and antimicrobial management. Pediatr Infect Dis J 2008,
27(5):400–405.
3. Raad II, Hanna HA: Intravascular catheter-related infections: new horizons
and recent advances. Arch Intern Med 2002, 162(8):871–878.
4. Karlowicz MG, Giannone PJ, Pestian J, Morrow AL, Shults J: Does
candidemia predict threshold retinopathy of prematurity in extremely
low birth weight (</=1000 g) neonates? Pediatrics 2000, 105(5):1036–1040.
5. Fairchild KD, Tomkoria S, Sharp EC, Mena FV: Neonatal Candida glabrata
sepsis: clinical and laboratory features compared with other Candida
species. Pediatr Infect Dis J 2002, 21(1):39–43.
6. Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN: Polymicrobial
bloodstream infections involving Candida species: analysis of patients
and review of the literature. Diagn Microbiol Infect Dis 2007, 59(4):401–406.
7. Brogden KA, Guthmiller JM, Taylor CE: Human polymicrobial infections.
Lancet 2005, 365(9455):253–255.
8. Downes KJ, Metlay JP, Bell LM, McGowan KL, Elliott MR, Shah SS:
Polymicrobial bloodstream infections among children and adolescents
with central venous catheters evaluated in ambulatory care. Clin Infect
Dis 2008, 46(3):387–394.9. Faix RG, Kovarik SM: Polymicrobial sepsis among intensive care nursery
infants. J Perinatol 1989, 9(2):131–136.
10. Weinstein MP, Reller LB, Murphy JR: Clinical importance of polymicrobial
bacteremia. Diagn Microbiol Infect Dis 1986, 5(3):185–196.
11. McKenzie FE: Case mortality in polymicrobial bloodstream infections.
J Clin Epidemiol 2006, 59(7):760–761.
12. Carlson E, Johnson G: Protection by Candida albicans of Staphylococcus
aureus in the establishment of dual infection in mice. Infect Immun 1985,
50(3):655–659.
13. Carlson E: Effect of strain of Staphylococcus aureus on synergism with
Candida albicans resulting in mouse mortality and morbidity.
Infect Immun 1983, 42(1):285–292.
14. Carlson E: Synergistic effect of Candida albicans and Staphylococcus
aureus on mouse mortality. Infect Immun 1982, 38(3):921–924.
15. Venkatesh MP, Pham D, Fein M, Kong L, Weisman LE: Neonatal coinfection
model of coagulase-negative Staphylococcus (Staphylococcus epidermidis)
and Candida albicans: fluconazole prophylaxis enhances survival and
growth. Antimicrob Agents Chemother 2007, 51(4):1240–1245.
16. Adam B, Baillie GS, Douglas LJ: Mixed species biofilms of Candida albicans
and Staphylococcus epidermidis. J Med Microbiol 2002, 51(4):344–349.
17. El-Azizi MA, Starks SE, Khardori N: Interactions of Candida albicans with
other Candida spp. and bacteria in the biofilms. J Appl Microbiol 2004,
96:1067–1073.
18. Flemming HC, Wingender J: The biofilm matrix. Nat Rev Microbiol 2010,
8(9):623–633.
19. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS: Extracellular DNA
required for bacterial biofilm formation. Science 2002, 295(5559):1487.
20. Steinberger RE, Holden PA: Extracellular DNA in single- and multiple-
species unsaturated biofilms. Appl Environ Microbiol 2005, 71(9):5404–5410.
21. Izano EA, Amarante MA, Kher WB, Kaplan JB: Differential roles of poly-N-
acetylglucosamine surface polysaccharide and extracellular DNA in
Staphylococcus aureus and Staphylococcus epidermidis biofilms.
Appl Environ Microbiol 2008, 74(2):470–476.
22. Hogan DA, Kolter R: Pseudomonas-Candida interactions: an ecological
role for virulence factors. Science 2002, 296(5576):2229–2232.
23. Peters BM, Jabra-Rizk MA, Scheper MA, Leid JG, Costerton JW, Shirtliff ME:
Microbial interactions and differential protein expression in Staphylococcus
aureus -Candida albicans dual-species biofilms. FEMS Immunol Med Microbiol
2010, 59(3):493–503.
24. Pammi M, Liang R, Hicks JM, Barrish J, Versalovic J: Farnesol decreases
biofilms of Staphylococcus epidermidis and exhibits synergy with
nafcillin and vancomycin. Pediatr Res 2011, 70(6):578–583.
25. Groicher KH, Firek BA, Fujimoto DF, Bayles KW: The Staphylococcus aureus
lrgAB operon modulates murein hydrolase activity and penicillin
tolerance. J Bacteriol 2000, 182(7):1794–1801.
26. Yang SJ, Dunman PM, Projan SJ, Bayles KW: Characterization of the
Staphylococcus aureus CidR regulon: elucidation of a novel role for
acetoin metabolism in cell death and lysis. Mol Microbiol 2006,
60(2):458–468.
27. Bayles KW: The biological role of death and lysis in biofilm development.
Nat Rev Microbiol 2007, 5(9):721–726.
28. Sharma-Kuinkel BK, Mann EE, Ahn JS, Kuechenmeister LJ, Dunman PM,
Bayles KW: The Staphylococcus aureus LytSR two-component regulatory
system affects biofilm formation. J Bacteriol 2009, 191(15):4767–4775.
29. Fujimoto DF, Brunskill EW, Bayles KW: Analysis of genetic elements
controlling Staphylococcus aureus lrgAB expression: potential role of
DNA topology in SarA regulation. J Bacteriol 2000, 182(17):4822–4828.
30. Rice KC, Mann EE, Endres JL, Weiss EC, Cassat JE, Smeltzer MS, Bayles KW:
The cidA murein hydrolase regulator contributes to DNA release and
biofilm development in Staphylococcus aureus. Proc Natl Acad Sci USA
2007, 104(19):8113–8118.
31. Tsai M, Ohniwa RL, Kato Y, Takeshita SL, Ohta T, Saito S, Hayashi H,
Morikawa K: Staphylococcus aureus requires cardiolipin for survival under
conditions of high salinity. BMC Microbiol 2011, 11:13.
32. Koprivnjak T, Zhang D, Ernst CM, Peschel A, Nauseef WM, Weiss JP:
Characterization of Staphylococcus aureus cardiolipin synthases 1 and 2
and their contribution to accumulation of cardiolipin in stationary phase
and within phagocytes. J Bacteriol 2011, 193(16):4134–4142.
33. Gilbert P, Maira-Litran T, McBain AJ, Rickard AH, Whyte FW: The physiology
and collective recalcitrance of microbial biofilm communities. Adv Microb
Physiol 2002, 46:202–256.
Pammi et al. BMC Microbiology 2013, 13:257 Page 12 of 12
http://www.biomedcentral.com/1471-2180/13/25734. Gustafsson E, Oscarsson J: Maximal transcription of aur (aureolysin) and
sspA (serine protease) in Staphylococcus aureus requires staphylococcal
accessory regulator R (sarR) activity. FEMS Microbiol Lett 2008,
284(2):158–164.
35. Liu Y, Manna A, Li R, Martin WE, Murphy RC, Cheung AL, Zhang G: Crystal
structure of the SarR protein from Staphylococcus aureus. Proc Natl Acad
Sci USA 2001, 98(12):6877–6882.
36. Manna A, Cheung AL: Characterization of sarR, a modulator of sar
expression in Staphylococcus aureus. Infect Immun 2001, 69(2):885–896.
37. Modun B, Kendall D, Williams P: Staphylococci express a receptor for
human transferrin: identification of a 42-kilodalton cell wall
transferrin-binding protein. Infect Immun 1994, 62(9):3850–3858.
38. Modun BJ, Cockayne A, Finch R, Williams P: The Staphylococcus aureus
and Staphylococcus epidermidis transferrin-binding proteins are
expressed in vivo during infection. Microbiology 1998,
144(Pt 4):1005–1012.
39. Mann EE, Rice KC, Boles BR, Endres JL, Ranjit D, Chandramohan L, Tsang LH,
Smeltzer MS, Horswill AR, Bayles KW: Modulation of eDNA release and
degradation affects Staphylococcus aureus biofilm maturation.
PLoS One 2009, 4(6):e5822.
40. Montanaro L, Poggi A, Visai L, Ravaioli S, Campoccia D, Speziale P,
Arciola CR: Extracellular DNA in biofilms. Int J Artif Organs 2011,
34(9):824–831.
41. Kaplan JB, Jabbouri S, Sadovskaya I: Extracellular DNA-dependent biofilm
formation by Staphylococcus epidermidis RP62A in response to
subminimal inhibitory concentrations of antibiotics. Res Microbiol 2011,
162(5):535–541.
42. Brunskill EW, Bayles KW: Identification and molecular characterization of a
putative regulatory locus that affects autolysis in Staphylococcus aureus.
J Bacteriol 1996, 178(3):611–618.
43. Yang SJ, Rice KC, Brown RJ, Patton TG, Liou LE, Park YH, Bayles KW: A
LysR-type regulator, CidR, is required for induction of the Staphylococcus
aureus cidABC operon. J Bacteriol 2005, 187(17):5893–5900.
44. Zhu T, Lou Q, Wu Y, Hu J, Yu F, Qu D: Impact of the Staphylococcus
epidermidis LytSR two-component regulatory system on murein
hydrolase activity, pyruvate utilization and global transcriptional profile.
BMC Microbiol 2010, 10:287.
45. Lou Q, Zhu T, Hu J, Ben H, Yang J, Yu F, Liu J, Wu Y, Fischer A, Francois P, et al:
Role of the SaeRS two-component regulatory system in Staphylococcus
epidermidis autolysis and biofilm formation. BMC Microbiol 2011, 11:146.
46. Qin Z, Ou Y, Yang L, Zhu Y, Tolker-Nielsen T, Molin S, Qu D: Role of
autolysin-mediated DNA release in biofilm formation of Staphylococcus
epidermidis. Microbiology 2007, 153(Pt 7):2083–2092.
47. Mueller LN, de Brouwer JF, Almeida JS, Stal LJ, Xavier JB: Analysis of a
marine phototrophic biofilm by confocal laser scanning microscopy
using the new image quantification software PHLIP. BMC Ecol 2006, 6:1.
48. Rouillard JM, Zuker M, Gulari E: OligoArray 2.0: design of oligonucleotide
probes for DNA microarrays using a thermodynamic approach.
Nucleic Acids Res 2003, 31(12):3057–3062.
49. Nailis H, Coenye T, Van Nieuwerburgh F, Deforce D, Nelis HJ: Development
and evaluation of different normalization strategies for gene expression
studies in Candida albicans biofilms by real-time PCR. BMC Mol Biol 2006,
7:25.
50. Ramage G, Vandewalle K, Wickes BL, Lopez-Ribot JL: Characteristics of
biofilm formation by Candida albicans. Rev Iberoam Micol 2001,
18(4):163–170.
doi:10.1186/1471-2180-13-257
Cite this article as: Pammi et al.: Biofilm extracellular DNA enhances
mixed species biofilms of Staphylococcus epidermidis
and Candida albicans. BMC Microbiology 2013 13:257.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
